Chinese and Foreign Clinical Medicine DOAJ Verified

Chinese and Foreign Clinical Medicine ISSN 3080-7611 (Print) ISSN 3080-762X (Online) CODEN: ZLYABX (Assigned by Chemical Abstracts Service, CAS) Publication Model: Gold Open Access under the Creative Commons Attribution 4.0 International License (CC BY 4.0). All content is permanently and freely accessible. Publisher: Quest Press Limited Publication Language: Chinese, English Publication Frequency: Bimonthly Discipline Category: Clinical Medicine and Translational Research Submission Language: Chinese (English title, abstract, keywords, author affiliations, and names must be provided) Distribution Support: China International Book Trading Corporation (CIBTC) Import Registration Number: G015Z110 1. Core Positioning and Distinctive Features The journal positions itself as “a bridge connecting clinical medicine research between China and the world.” Its core features are clinical practicability, international frontiers, and evidence-based innovation. We emphasize a clinical problem-oriented research design, focus on the translation and application of research findings into clinical practice, commit to promoting the optimization of diagnosis and treatment plans based on evidence-based medicine, and facilitate in-depth exchange and mutual learning of clinical research methods and outcomes between China and foreign countries. 2. Journal Introduction Chinese and Foreign Clinical Medicine is an international academic journal focusing on challenging issues in clinical practice and advances in frontier medicine. The journal is dedicated to publishing original research, evidence-based medicine evaluations, and technological innovation achievements with clear clinical guiding value, covering key areas such as disease diagnosis, treatment optimization, prognosis assessment, and healthcare quality improvement. The journal aims to provide a high-level academic exchange platform for clinicians, researchers, and healthcare administrators, promoting the globalization and precision development of clinical medicine. 3. Scope of Submission The journal invites original research and practical papers in the following (but not limited to) areas: Innovation in Disease Diagnosis and Treatment: Analysis of difficult cases, optimization of diagnostic criteria, innovation in treatment pathways, personalized treatment plans Clinical Translational Research: Biomarker validation, exploration of targeted therapies, clinical evaluation of medical technologies, innovative application of medical devices Evidence-Based Medicine Practice: Systematic reviews/Meta-analyses, development of clinical guidelines, real-world studies, optimization of medical decision-making Healthcare Quality and Safety: Patient safety systems, healthcare quality control indicators, clinical pathway management, prevention of adverse events Interdisciplinary Applications: Artificial intelligence-assisted diagnosis, digital medical technologies, precision medicine practices, multidisciplinary collaboration models Global Health Research: Comparative studies of disease spectra, comparison of healthcare systems, cross-border medical cooperation, advances in rare disease diagnosis and treatment Medical Education and Humanities: Cultivation of clinical competencies, medical simulation teaching, doctor-patient communication research, discussion of medical ethics 4. Submission Guidelines Manuscript Requirements: Submissions must be unpublished original clinical research. Research design must comply with ethical norms, data must be authentic and complete, statistical analysis must be appropriate, and conclusions must have clear guiding significance for clinical practice. The journal employs a strict double-blind peer review system. Submission Language: Manuscripts must be written in Chinese. Required Elements: Please provide complete bilingual (Chinese and English) information upon submission: Article title (Chinese and English) Author information: Names and affiliations (in both Chinese and English) of all authors, and a brief biography of the first author (including clinical specialty and contact details) Abstract: Structured bilingual abstracts (Chinese and English) must include Objective, Methods, Results, and Conclusion Keywords: 3–5 bilingual keywords (Chinese and English). Use of MeSH (Medical Subject Headings) terms is recommended. Ethical Statement: For research involving human or animal experiments, please provide the ethical review approval number. 5. Aims and Vision The journal’s vision is to become an authoritative academic platform connecting China and the world in the field of clinical medicine. We are committed to promoting evidence-based innovation in clinical practice, facilitating the sharing and integration of global high-quality medical resources. By disseminating scientific research achievements with direct clinical value, we ultimately aim to serve the improvement of healthcare service quality and patient health outcomes. 6. Open Access Policy The journal strictly adheres to the Gold Open Access publishing model. All published articles are disseminated under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Upon publication, articles are made permanently and freely accessible, allowing clinicians and researchers to use the content for lawful, non-commercial purposes, provided that proper attribution is given to the original author(s) and source. For full license details, visit: https://creativecommons.org/licenses/by/4.0/